MA
ARNA

MUFG Americas’s Arena Pharmaceuticals Inc ARNA Stock Holding History

MUFG Americas’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-177
Closed -$6K – 1048
2017
Q4 		$6K Sell
177
-108
-38% -$3.08K ﹤0.01% 889
2017
Q3 		$7K Sell
285
-288
-50% -$6.61K ﹤0.01% 913
2017
Q2 		$10K Sell
573
-102
-15% -$1.4K ﹤0.01% 852
2017
Q1 		$10K Buy
675
+121
+22% +$1.79K ﹤0.01% 854
2016
Q4 		$8K Buy
554
+64
+13% +$991 ﹤0.01% 891
2016
Q3 		$9K Buy
+490
New +$8.13K ﹤0.01% 879

Other funds holding ARNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

MUFG Americas's ARNA Position: Q1 2018 in Review

MUFG Americas sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2018, closing a stake of 177 shares — an estimated $6K sold.

MUFG Americas first reported a position in ARNA in Q3 2016 and held it in 6 quarters. The position peaked at $10K in Q2 2017. 170 funds tracked by Wall St. Rank hold ARNA as of Q1 2018.

  • MUFG Americas reported no remaining Arena Pharmaceuticals Inc position as of Q1 2018 after selling out during the quarter.
  • MUFG Americas sold 177 Arena Pharmaceuticals Inc shares in Q1 2018, an estimated $6K.
  • MUFG Americas first reported a position in Arena Pharmaceuticals Inc in Q3 2016 and held it in 6 quarters.
  • MUFG Americas's Arena Pharmaceuticals Inc position peaked at $10K in Q2 2017.
  • 170 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.